Clinical Trial Search

Primary: Change From Baseline in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) Severity Subscale Score Based on Blinded Rater Assessment at Week 4 After the 8th…

Primary: Number of Participants Who Achieved Clinical Remission at Day 56 — 56; 52 Participants

Primary: Change From Baseline in Worst Pain Scores as Assessed by the Brief Pain Inventory-Short Form (BPI-SF) at Week 8 — 7.26; -2.61 score on a scale — p=0.0746

Primary: Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites — 296.2407…

Primary: Mean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session — 0.74 score on a scale

Primary: Absolute Difference (3 Years Post Nitrate- 3 Years Pre Nitrate) In-Scaffold Mean Lumen Diameter (MLD) — 0.05; 0.06 mm — p=0.49

Primary: Number of Participants With Different Epidemiological Features — 287; 100; 68; 56 patients

Primary: Time to First Bowel Movement — 93.3; 100.4; 91.3 hours — p=0.944

Primary: Change From Baseline to 24 Weeks of the Mean of the 24-hour Standard Deviation Score (SDS) Profile for 17-OHP — -0.403; -0.172 Z-score — p==0.5521

Primary: Proportion of Patients Who do Not Meet the Criteria to Move Forward With Roux en Y Gastric Bypass (RYGB) — 8; 19 Participants

Primary: Duration of Intraocular Gas — 17.1; 18.1 days

Primary: Daily Combined Score (DCS) — -4.41; -1.61 DCS (daily combined score)

Primary: Percentage of Subjects Who Are in Amenorrhea at the End of All Four Treatment Courses — 48.7; 60.5 percentage of subjects

Primary: Time to First Bowel Movement — 4.4; 4.8; 4.6 days — p=0.4259

Primary: Percentage of Participants With Scalp Physician Global Assessment (ScPGA) Score of Clear (0) or Almost Clear (1) With at Least a 2-Point Reduction From Baseline — 13.7…